miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1

Table 1 The relationship of miR-363 with the clinicopathological features in patients with ccRCC

Clinicopathological features	Number (n = 77)	MiR-363 expression (mean ± SD)	P value
Age (years)
< 60	45	0.00134 ± 0.00169	0.233
≥ 60	32	0.00089 ± 0.00152	0.233
Gender
Male	65	0.00121 ± 0.00169	0.400
Female	12	0.00078 ± 0.00121	0.400
Fuhrman grade
I–II	57	0.00146 ± 0.00178	0.004
III–IV	20	0.00026 ± 0.00041	0.004
T staging
T1–T2	59	0.00139 ± 0.00176	0.016
T3–T4	18	0.00035 ± 0.00064
Overall TNM staging
I–II	54	0.00151 ± 0.00180	0.003
III–IV	23	0.00031 ± 0.00057	0.003
Microvascular invasion
No	58	0.00141 ± 0.00177	0.012
Yes	19	0.00035 ± 0.00063	0.012
Tumor necrosis
No	49	0.00110 ± 0.00160	0.754
Yes	28	0.00123 ± 0.00170	0.754

miR‐363 microRNA‐363, ccRCC clear cell renal cell carcinoma, SD standard deviation, TNM tumor node metastasis

ISSN: 1475-2867